septerna - Search News

Order byBest matchMost fresh

News

Obesity, Novo Nordisk and Septerna

· 5h · on MSN

Novo Nordisk and Septerna Collaborate on Oral Medicines for Obesity and Other Diseases

The $2.2 billion deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other cardiometabolic diseases.

Continue reading

· 2h · on MSN

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments

· 5h · on MSN

Novo Nordisk in pact with Septerna for oral obesity drugs

Indianapolis Business Journal2h

Novo Nordisk inks $2.2B deal to develop weight-loss pill to rival Lilly’s orforglipron

Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last ...

1h

US FDA expands use of Merck's cancer drug for adrenal gland tumors

The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results